TC Medical(SH:600763)2016-04-27 16:00Financial Performance - Operating revenue for the period was CNY 175,649,104.98, representing an increase of 17.82% year-on-year[5]. - Net profit attributable to shareholders was CNY 37,144,966.66, up 18.15% from the same period last year[5]. - Basic earnings per share increased by 20.00% to CNY 0.12[5]. - The net profit after deducting non-recurring gains and losses was CNY 35,566,644.44, an increase of 20.06% year-on-year[5]. - Total operating revenue for Q1 2016 was CNY 175,649,104.98, an increase of 17.9% compared to CNY 149,080,553.56 in the same period last year[25]. - Net profit for Q1 2016 reached CNY 37,677,587.80, representing a 17.5% increase from CNY 32,097,650.81 in Q1 2015[26]. - The company reported a total comprehensive income of CNY 37,677,587.45 for Q1 2016, compared to CNY 32,097,650.83 in Q1 2015[26]. Cash Flow - The net cash flow from operating activities was negative CNY 43,562,154.76, a decline of 389.49% compared to the previous year[5]. - Cash flow from operating activities in Q1 2016 was negative CNY 43,562,154.76, a decline from positive CNY 15,047,728.09 in Q1 2015[30]. - Net cash outflow from operating activities was CNY -61,377,343.24, compared to CNY -3,617,837.76 in the same period last year, indicating a worsening cash flow situation[32]. - Total cash and cash equivalents at the end of Q1 2016 were CNY 104,041,640.37, down from CNY 130,366,398.69 at the end of the previous year[33]. - The company experienced a decrease in cash and cash equivalents by CNY 51,459,343.24 during the quarter[33]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,311,754,200.02, a decrease of 1.37% compared to the end of the previous year[5]. - Total liabilities decreased from ¥436,404,616.15 to ¥380,510,770.24, a decrease of approximately 12.8%[21]. - Owner's equity increased from ¥893,565,842.33 to ¥931,243,429.78, an increase of about 4.2%[22]. - Cash and cash equivalents decreased from ¥155,500,983.61 to ¥104,041,640.37, a decline of approximately 33.1%[22]. - Accounts receivable increased from ¥14,560,575.68 to ¥22,223,845.82, an increase of about 52.5%[22]. - Inventory increased from ¥485,823.28 to ¥2,359,989.77, a significant increase of approximately 385.5%[22]. Expenses - Total operating costs for Q1 2016 were CNY 133,364,483.09, up 21.7% from CNY 109,586,535.46 in Q1 2015[25]. - Sales expenses increased by 96.46% to CNY 3,153,237.14, mainly due to higher advertising costs[13]. - Management expenses rose to CNY 24,545,996.14 in Q1 2016, compared to CNY 22,049,619.45 in the same period last year[25]. - Financial expenses surged by 536.51% to CNY 4,228,190.58, primarily due to increased loan interest[13]. Investments and Acquisitions - The company plans to establish a new dental hospital with a registered capital of CNY 6 million, where it will hold a 60% stake[14]. - The company is in the process of acquiring 95.67% of Haijun Technology and 90% of Yinghu Chuang and Yinghu Shared through a share issuance[15]. - Investment income for Q1 2016 was CNY 1,007,518.37, up from CNY 316,124.58 in the previous year[25]. - Investment cash flow net amount fell by 58.58% to -CNY 21,210,569.04 due to increased cash payments for fixed asset purchases[13]. Shareholder Information - The total number of shareholders at the end of the reporting period was 19,814[10]. - The largest shareholder, Hangzhou Baoqun Industrial Group Co., Ltd., held 33.75% of the shares[10].